|By PR Newswire||
|August 21, 2014 04:26 AM EDT||
-- Patient recruitment-retention leader MediciGlobal expands its international team as the company continues to invest in best in class talent
PHILADELPHIA and LONDON, Aug. 21, 2014 /PRNewswire/ -- MediciGlobal Ltd., a global leader in patient recruitment and retention for clinical trials, today announced the appointment of Linda Capsey, PhD as Vice President Project Management and Innovation. With more than 20 years industry experience, Dr. Capsey joins MediciGlobal's dynamic management team as a leader in building and managing high performing patient recruitment – retention teams for global clinical trials. In her position, Dr. Capsey will provide strategic and operational oversight for recruitment-retention program development, site training workshops for patient communications and informed consent, and serve as a consultant to biopharmaceutical companies for patient recruitment-retention planning and feasibility.
Previously, Linda served as Client Services Director at the global patient recruitment firm, Fast4wD Ogilvy, UK, a position she held for nearly a decade. Most recently Dr. Capsey has focused on medical education programs with Ogilvy 4D, UK. Previously Dr. Capsey spent 12 years at GlaxoSmithKline in marketing and clinical research, holding a various position that included Market Access Strategy, Marketing Management, Pipeline Strategy Management and Clinical Trials Management. Dr. Capsey obtained her PhD in Molecular Biology from the National Institute for Medical Research - London, UK
With a track record in clinical trials management, pharmaceutical marketing and creative healthcare communications, Linda Capsey describes herself as a passionate "Communications Scientist". "I get my kicks out of taking complex scientific information and distilling it into simple, tailored and impactful clinical communications for a range of different patient, public and healthcare professional audiences." She is equally passionate about delivering services in the context of simple, clear, transparent and efficient procedures underpinned by quality control and a clear understanding of the unique regulatory and ethical circumstances which apply to clinical trial communications.
According to MediciGlobal President, Liz Moench "MediciGlobal's highly skilled international staff with expertise in clinical trial recruitment as well as significant experience in social marketing, patient advocacy, health communications, site support and performance metrics provide clients with the global solutions they are looking for." Moench adds "Our track record is driven by our people. Our teams of experts are not generalists. We hire the best in the marketplace because we mix consumer marketing and communications skills with scientific and regulatory understanding of the clinical trial process, to produce programmes that step up patient recruitment and improve retention."
"As an innovative global leader dedicated to optimizing the patient recruitment through innovation, technology and our unique patient-centric approach, we require innovative leadership to foster our 'Glocal' approach that requires our recruitment-retention teams to think globally and act locally," says Liz Moench, CEO of MediciGlobal. "Linda's international experience, and collaborative leadership style is an excellent strategic fit with our glocal culture."
MediciGlobal's diverse team consists of medical professionals, nurses, digital marketers, patient advocates, writers, designers and business analysts. MediciGlobal's business is 100% patient recruitment-retention focused. For more than 24 years Medici has supported biopharmaceutical companies in accelerating clinical trials through innovative and cost effective recruitment-retention programs across a multitude of disease areas. More importantly MediciGlobal's metrics demonstrate the impact of its programmes on time and cost saved. Core global programmes are run from Medici's offices based in Europe and the USA.
Moench observes that many pharmaceutical companies are experiencing significant delays in the clinical development process. The most significant bottleneck is due to difficulties with identifying, enrolling, and retaining suitable patients for the clinical trials required for product registration."MediciGlobal's services and our experienced staff have refined processes, methodologies and strategies to address this need." She adds.
MediciGlobal is in the business of making a meaningful difference to patient health by identifying and engaging patients for clinical trials, and by building deep and lasting connections with its stakeholders. Its clinical trial recruitment practices are guided by global standards and a concern for the lives of patients who put their trust in the company to help match them to the right clinical trial. The Medici team is ensuring that those who participate in these trials fully understand the clinical trial process, and that their participation is guarded by strict privacy policies. MediciGlobal meets BBB OnLine® and WBENC accreditation standards and is certified as a Safe Harbor company. Visit www.mediciglobal.com to learn more.
Mar. 27, 2017 08:30 AM EDT Reads: 1,194
Mar. 27, 2017 08:15 AM EDT Reads: 3,024
Mar. 27, 2017 08:15 AM EDT Reads: 3,055
Mar. 27, 2017 08:00 AM EDT Reads: 4,237
Mar. 27, 2017 07:45 AM EDT Reads: 1,044
Mar. 27, 2017 05:00 AM EDT Reads: 6,170
Mar. 27, 2017 05:00 AM EDT Reads: 11,049
Mar. 27, 2017 03:45 AM EDT Reads: 2,978
Mar. 27, 2017 03:15 AM EDT Reads: 3,164
Mar. 27, 2017 03:00 AM EDT Reads: 3,003
Mar. 27, 2017 02:15 AM EDT Reads: 4,185
Mar. 27, 2017 01:45 AM EDT Reads: 2,985
Mar. 27, 2017 01:45 AM EDT Reads: 2,925
Mar. 27, 2017 01:15 AM EDT Reads: 1,869
Mar. 27, 2017 12:45 AM EDT Reads: 2,122